Skip to content
★ Sign in to follow
RH

Robert Huizinga

Aurinia Pharmaceuticals Inc.
Total declarations
16
Company
1
▲ Purchases (3 ops.)
€263k
▼ Sales (7 ops.)
€4.8M

Latest filing published 07 Mar 2022 for Aurinia Pharmaceuticals Inc..

Filing timeline

BuySale
Robert Huizinga

Insider track record

Disclosed buys
3
Disclosed sells
7
Signal history

Robert Huizinga: trading record in brief

This profile gathers the share dealings of Robert Huizinga in Aurinia Pharmaceuticals Inc. We count 16 filings; the first trade dates from 22 June 2016 and the latest from 2 March 2022.

Market trades split into 3 purchases (€263k) and 7 sales (€4.8M). Netting one side against the other leaves €4.5M of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 option exercises.

The median purchase comes to €28k.

Most recently, on 7 March 2022, the filings show an option exercise in Aurinia Pharmaceuticals Inc. The clock since the last published purchase (27 October 2021) now reads 1,839 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Robert Huizinga

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations